此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Lifestyle Intervention for Pakistani Women in Oslo (InnvaDiab)

2014年6月24日 更新者:Gerd Holmboe-Ottesen、University of Oslo

Evaluation of a Lifestyle Intervention to Prevent Type 2 Diabetes/Metabolic Syndrome Among Pakistani Immigrants - Focusing on Changes in Diet and Physical Activity

Immigrants from South Asia in Norway have a high prevalence of type 2 diabetes and conditions related to the metabolic syndrome. It has been documented that these conditions may be prevented by changes in lifestyle. No previous intervention studies on immigrants with focus on diet and physical activity have been carried out in Norway. This project concerns a randomized controlled trial with intervention to change diet and physical activity in 200 high risk female Pakistani immigrants living in Oslo. The intervention will be evaluated both in terms of outcome and process.

研究概览

详细说明

Objectives:

  1. To evaluate the health effects of systematic dietary education and counselling and physical training in a group of Pakistani women with high risk of type 2 diabetes.
  2. To evaluate the intervention process in order to identify the most effective methods of intervention in regard to diet and physical activity for immigrant women of Pakistani origin.

Background: Immigrants from South Asia have a high prevalence of type 2 diabetes, which may be prevented by intensive on physical activity and diet. This application concerns intervention with diet and physical activity in female (ongoing study) and male (extended study) Pakistani immigrants living in Oslo to reduce their risk for these diseases.

Intervention design: The subjects will be 200 women randomized into an intervention group and a control group (100 in each). The women are being recruited from a township in Oslo with a high proportion of immigrants by using a network approach. Inclusion criteria is based on a risk score developed by Ramachandran et al for Asian Indians, entailing age, Body Mass Index, waist circumference, family history of diabetes and sedentary physical activity.

The intervention will include a combination of individual counselling and group sessions. The intervention group will be divided into subgroups of 10-12 subjects. Each subgroup will have 10 group sessions on diet/lifestyle in the 6 months the intervention period lasts, and will additionally have the possibility to join a cultural adapted exercise program of low intensity twice a week. This includes indoor activities (exercise with music) and outdoor activities (walking groups).

Evaluation: The main end point of the intervention will be the fasting and 2-h plasma glucose value after an oral glucose tolerance test (OGTT). This will be measured at baseline and after 6 months of intervention.

Secondary end-points will be Serum lipid profile (e.g. triglycerides, High-Density Lipoprotein-cholesterol) ; HbA1c ; C-peptide ; serum insulin; serum albumin; body weight; waist and hip circumference; maximum heart rate on treadmill test; self-reported level of intensity, duration and frequency of physical activity; self-reported level of "Stages of change" in regard to motivation and behavioural change; self- reported subjective health complaints; self-reported coping strategies; self-reported sleeping habits.

Dietary information will be collected by 2 x 48 hours dietary recalls. The intake of energy and nutrients will be calculated from the recalls, as well as the intake of food groups.The diet will also be evaluated by a culturally adapted food frequency questionnaire including 20 food groups (with portion sizes). In addition, the use of cooking oils will be registered by questions about the type and quantity oil used per time unit in the household. Additionally, information on knowledge and perceptions on diet and health before and after the intervention will be registered.

Physical activity will be registered using an advanced continuous body monitor, SenseWear Armband yielding information on total energy expenditure, level of intensity, duration and frequency of physical activity, duration of lying down, duration of sleeping, and sleeping quality.

The completion of the questionnaires will take the form of an interview by Urdu speaking staff.

研究类型

介入性

注册 (实际的)

198

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Holmlia, Oslo
      • Oslo、Holmlia, Oslo、挪威、1255
        • Primary Health Care Health Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

25年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion Criteria:

  • Risk score developed by Ramachandran et al for Asian Indians:

    • BMI, waist circumference, family history of diabetes and sedentary physical activity

Exclusion Criteria:

  • Type 1 diabetes.
  • Positive auto antibodies.
  • Diagnosis of type 2 diabetes more than 6 months.
  • Medication for type 2 diabetes.
  • Pregnancy at intervention start.
  • Suffering from heart attack or stroke the last 3 months.
  • Already participating in organised physical exercise.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Intervention
The intervention group was divided into nine subgroups of ten to twelve women who were offered six educational sessions, each lasting 2 h, during a 7 +- 1-month period. The main focus was on the physiological importance of blood glucose and its regulation by diet and physical activity, and on knowledge about the Pakistani lifestyle in Pakistan and Norway
The intervention will include a combination of individual counselling group sessions. The intervention groups will be divided into subgroups of 10-12 subjects. Each group will have 10 group sessions on diet/lifestyle in the 6 months the intervention period lasts, and will additionally have the possibility to join a culturally adapted exercise program of low intensity twice a week.
无干预:Control
One lesson recieved after post-test

研究衡量的是什么?

主要结果指标

结果测量
大体时间
The Fasting Plasma Glucose Value, Baseline
大体时间:baseline
baseline
Plasma Glucose 2 h After Oral Glucose Tolerance Test, Baseline
大体时间:baseline
baseline
The Fasting Plasma Glucose, Post-test
大体时间:post-test
post-test
Plasma Glucose, 2-h, Post-test
大体时间:post-test
post-test

次要结果测量

结果测量
大体时间
HbA1c, Baseline
大体时间:baseline
baseline
C-peptide, 0-h, Baseline
大体时间:baseline
baseline
C-peptid, 2-h, Baseline
大体时间:baseline
baseline
Insulin, 0-h, Baseline
大体时间:baseline
baseline
Insulin, 2-h, Baseline
大体时间:baseline
baseline
High-Density Lipoprotein Cholesterol, Baseline
大体时间:baseline
baseline
Triglycerides, Baseline
大体时间:baseline
baseline
Systolic Blood Pressure, Baseline
大体时间:baseline
baseline
Diastolic Blood Pressure, Baseline
大体时间:baseline
baseline
Waist Circumference, Baseline
大体时间:baseline
baseline
Body Mass Index, Baseline
大体时间:baseline
baseline
Intake of Vegetables, Fruit and Fruit Juice, Baseline
大体时间:baseline
baseline
Intake of Soft Drinks With Added Sugar, Baseline
大体时间:baseline
baseline
Intake of Red Meat, Baseline
大体时间:baseline
baseline
Intake of Poultry, Baseline
大体时间:baseline
baseline
Intake of Fish, Baseline
大体时间:baseline
baseline
HbA1C, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
C-peptid, 0-h, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
C-peptid, 2-h, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Insulin, 0-h, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Insulin, 2-h, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
High-Density Lipoprotein Cholesterol, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Triglycerides, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Systolic Blood Pressure, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Diastolic Blood Pressure, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Waist Circumference
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Body Mass Index, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Vegetables, Fruit and Fruit Juice, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Soft Drinks With Added Sugar, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Red Meat, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Poultry, Post-test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Fish, Post Test
大体时间:post-test, after completion of all six group sessions
post-test, after completion of all six group sessions

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Gerd Holmboe-Ottesen, Dr. Philos.、University of Oslo

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2006年4月1日

初级完成 (实际的)

2008年9月1日

研究完成 (实际的)

2008年9月1日

研究注册日期

首次提交

2007年1月19日

首先提交符合 QC 标准的

2007年1月19日

首次发布 (估计)

2007年1月22日

研究记录更新

最后更新发布 (估计)

2014年7月21日

上次提交的符合 QC 标准的更新

2014年6月24日

最后验证

2014年4月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

代谢综合征的临床试验

  • Sanford Health
    National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research Foundation; Cornelia... 和其他合作者
    招聘中
    线粒体疾病 | 色素性视网膜炎 | 重症肌无力 | 嗜酸性胃肠炎 | 多系统萎缩 | 平滑肌肉瘤 | 脑白质营养不良 | 肛瘘 | 脊髓小脑性共济失调3型 | 弗里德赖希共济失调 | 肯尼迪病 | 莱姆病 | 噬血细胞性淋巴组织细胞增生症 | 脊髓小脑性共济失调1型 | 脊髓小脑性共济失调2型 | 脊髓小脑共济失调6型 | 威廉姆斯综合症 | 先天性巨结肠症 | 糖原贮积病 | 川崎病 | 短肠综合症 | 低磷血症 | Leber先天性黑蒙 | 口臭 | 贲门失弛缓症 | 多发性内分泌肿瘤 | 利综合症 | 艾迪生病 | 多发性内分泌肿瘤 2 型 | 硬皮病 | 多发性内分泌肿瘤 1 型 | 多发性内分泌肿瘤 2A 型 | 多发性内分泌肿瘤 2B 型 | 非典型溶血性尿毒症综合征 | 胆道闭锁 | 痉挛性共济失调 | WAGR综合症 | 无虹膜 | 短暂性失忆症 | 马尾综合症 | Refsum 疾病 | 复发性呼吸... 及其他条件
    美国, 澳大利亚
3
订阅